A company focused on cell therapy, described as bringing a new age in cell therapy.

OverT Bio

CrUX Dataset

CrUX Top 50m

Laboratory Manager

Miao Chen

Co-Founder and CEO

Mat Legut

New York Seed Stage Companies With Fewer Than 1000 Employees

Greater New York Area Seed Stage Companies With Fewer Than 100 Employees

Greater New York Area Companies With Fewer Than 10 Employees (Top 10K)

East Coast Companies (Top 10K)

OverT Bio operates as a biotech company that provide cell therapy for cancers.. The company's cell therapies identify and develop novel genetic modifications that will help immune cells overcome barriers created by tumors and lead to effective and durable immunotherapies, helping the healthcare industry to identify and cure cancer.

Artis Ventures (AV)

Wing Venture Capital

Seed Round - OverT Bio

New York

United States

North America

OverT Bio Receives $120K G-Rex® Grant to Propel Solid Tumor Cell Therapy Advancements

Nona Biosciences Enters Strategic Collaboration with OverT Bio to Advance Next-Generation Cell Therapies for Solid Tumors

OverT Bio debuts with $16M to find new ways to make solid cancer cell therapies

OverT Bio Raises $16M in Seed Funding

Ana Maria Gonzalez on LinkedIn: OverT Bio debuts with $16M to find new ways to make solid cancer cell…

A platform for pooled functional screening to develop engineered immune cells for cancer therapy.

A synthetic genomics platform designed to create next-generation engineered immune cells for treating solid tumors.

India

Asia

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Jul 18, 2024 5:04 AM	1d9d7457
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 25, 2024 9:06 AM	38e19b49
crunchbase profile	general	Nov 25, 2024 9:11 AM	55c96c38
li profile	general
translate crunchbase fundingrounds	general	Nov 25, 2024 2:00 PM	d97a625b
peers	general	Jul 18, 2024 5:04 AM	6ff26fd4
news basic	general	Jul 18, 2024 5:04 AM	090dadec
bundesanzeiger	filings
financials download nd	financials
private financials	financials

OVER

BIO:OVERT

OverT Bio